{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:09:20Z","timestamp":1779246560062,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009967","name":"Xinjiang Production and Construction Corps","doi-asserted-by":"publisher","award":["2023AB009\\u201304"],"award-info":[{"award-number":["2023AB009\\u201304"]}],"id":[{"id":"10.13039\/501100009967","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.biopha.2026.119260","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:32:07Z","timestamp":1773822727000},"page":"119260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro activity and moderate in vivo efficacy of a novel \u03b2-carboline derivative against acute Toxoplasma gondii tachyzoites"],"prefix":"10.1016","volume":"198","author":[{"given":"Yan-chuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GVLZAPAR","family":"Tohniyaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing-gang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119260_bib1","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1073\/pnas.1015980108","article-title":"Polymorphic family of injected pseudokinases is paramount in Toxoplasma gondii virulence","volume":"108","author":"Reese","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2026.119260_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin. Microbiol Rev."},{"issue":"7","key":"10.1016\/j.biopha.2026.119260_bib3","first-page":"519","article-title":"Brains and brawn","volume":"33","author":"Wohlfert","year":"2017","journal-title":"Toxoplasma gondii Infect. Cent. Nerv. Syst. Skelet. Muscle Trends Parasitol."},{"key":"10.1016\/j.biopha.2026.119260_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/metabo13040476","article-title":"Vitro evaluation reveals effect and mechanism of artemether against Toxoplasma gondii","volume":"13","author":"Xu","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2026.119260_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpddr.2020.12.003","article-title":"HDAC inhibitors tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics","volume":"15","author":"Araujo-Silva","year":"2020","journal-title":"Int J. Parasitol. Drugs Drug Resist"},{"key":"10.1016\/j.biopha.2026.119260_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural products as sources of new drugs over the last 25 years","volume":"70","author":"Newman","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.biopha.2026.119260_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.biopsych.2012.01.003","article-title":"The Relationship between toxoplasma gondii infection and mood disorders in the third national health and nutrition survey","volume":"72","author":"Pearce","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.biopha.2026.119260_bib8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00018-013-1491-1","article-title":"Mechanisms of cellular invasion by intracellular parasites","volume":"71","author":"Walker","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2026.119260_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-019-1067-8","article-title":"Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol","volume":"8","author":"Feliciano-Alfonso","year":"2019","journal-title":"Syst. Rev."},{"key":"10.1016\/j.biopha.2026.119260_bib10","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ejmech.2018.08.027","article-title":"\u03b2-Carboline alkaloid monomers and dimers: occurrence, structural diversity, and biological activities","volume":"157","author":"Dai","year":"2018","journal-title":"Eur. J. Med Chem."},{"key":"10.1016\/j.biopha.2026.119260_bib11","first-page":"199","article-title":"Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids","volume":"7","author":"Moloudizargari","year":"2013","journal-title":"Pharm. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2026.119260_bib12","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1248\/cpb.59.388","article-title":"Inhibitory effects of herbal alkaloids on the tumor necrosis factor-\u03b1 and nitric oxide production in lipopolysaccharide-stimulated RAW264 macrophages","volume":"59","author":"Yamazaki","year":"2011","journal-title":"Chem. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.biopha.2026.119260_bib13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.fitote.2010.04.004","article-title":"Antibacterial and antifungal activities of \u03b2-carboline alkaloids of Peganum harmala (L) seeds and their combination effects","volume":"81","author":"Nenaah","year":"2010","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2026.119260_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/14756366.2018.1497619","article-title":"Synthesis and biological evaluation of novel N9-heterobivalent \u03b2-carbolines as angiogenesis inhibitors","volume":"34","author":"Guo","year":"2019","journal-title":"J. Enzym. Inhib. Med Chem."},{"issue":"8","key":"10.1016\/j.biopha.2026.119260_bib15","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2221-1691(12)60116-6","article-title":"A review on medicinal importance, pharmacological activity and bioanalytical aspects of \u03b2-carboline alkaloid \"Harmine\"","volume":"2","author":"Patel","year":"2012","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.biopha.2026.119260_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.716534","article-title":"vitro effect of harmine alkaloid and its N-methyl derivatives against Toxoplasma gondii","volume":"12","author":"Alomar","year":"2021","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.biopha.2026.119260_bib17","doi-asserted-by":"crossref","DOI":"10.1590\/s1984-29612024053","article-title":"vitro anti-parasitic effect of the alkaloids harmaline and piperine on Toxoplasma gondii","volume":"33","author":"Carreira","year":"2024","journal-title":"Rev. Bras. Parasitol. Vet."},{"key":"10.1016\/j.biopha.2026.119260_bib18","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1128\/AAC.00328-12","article-title":"Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin","volume":"56","author":"Shahinas","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.biopha.2026.119260_bib19","first-page":"386","article-title":"Cytotoxic Effects of Harmine and Its Derivative H-2-168 on SH-SY5Y Cells","volume":"39","author":"Yimaierjiang","year":"2023","journal-title":"J. Clin. Basic Transl. Res"},{"issue":"19","key":"10.1016\/j.biopha.2026.119260_bib20","first-page":"4652","article-title":"4-Thiazolidinone derivatives as potential anti-Toxoplasma gondii agents: synthesis, biological evaluation and molecular modeling studies","volume":"24","author":"Chimenti","year":"2014","journal-title":"Bioorg. Med Chem. Lett."},{"issue":"12","key":"10.1016\/j.biopha.2026.119260_bib21","first-page":"3677","article-title":"Anti-Toxoplasma gondii activity of coumarin derivatives: synthesis, biological evaluation and molecular docking studies","volume":"119","author":"Khalil","year":"2020","journal-title":"Parasitol. Res"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226002933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:56:13Z","timestamp":1779245773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226002933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":21,"alternative-id":["S0753332226002933"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119260","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro activity and moderate in vivo efficacy of a novel \u03b2-carboline derivative against acute Toxoplasma gondii tachyzoites","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119260"}}